1. Statins may reduce disease recurrence in patients with ulcerated primary melanoma
   L.A. Schuckmann et al, 2020, British Journal of Dermatology CrossRef
2. Risk factors for specific causes of death following pediatric heart transplant: An analysis of the registry of the International Society of Heart and Lung Transplantation
   R. D. Vanderlaan et al, 2015, Pediatric Transplantation CrossRef
3. Simvastatin inhibits the expression of stemness-related genes and the metastatic invasion of human cancer cells via destruction of the cytoskeleton
   Rosarita Tatè et al, 2017, International Journal of Oncology CrossRef
4. Novel prospects of statins as therapeutic agents in cancer
   Simona Pisanti et al, 2014, Pharmacological Research CrossRef
5. Statins Alleviate Tumor Hypoxia in Prostate Cancer Models by Decreasing Oxygen Consumption: An Opportunity for Radiosensitization?
   Donatienne d’Hose et al, 2022, Biomolecules CrossRef
6. Scrutinising the role of simvastatin in a patient of Pachyonychia Congenita with KRT6A gene mutation
   Shruti Sharma et al, 2022, Australasian Journal of Dermatology CrossRef
7. Signal pathways of melanoma and targeted therapy
   Weinan Guo et al, 2021, Signal Transduction and Targeted Therapy CrossRef
8. Effect of simvastatin on cell proliferation and Ras activation in canine tumour cells
   Kosuke Kobayashi et al, 2021, Veterinary and Comparative Oncology CrossRef
9. Computational Drug Repositioning Identifies Statins as Modifiers of Prognostic Genetic Expression Signatures and Metastatic Behavior in Melanoma
   Wesley Y. Yu et al, 2021, Journal of Investigative Dermatology CrossRef
10. Assessment in vitro of interactions between anti-cancer drugs and noncancer drugs commonly used by cancer patients
    Claes R. Andersson et al, 2023, Anti-Cancer Drugs CrossRef
11. Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence
    Antonio C. Fuentes-Fayos et al, 2023, eBioMedicine CrossRef
12. Pro-oncogenic Roles of HLXB9 Protein in Insulinoma Cells through Interaction with Nono Protein and Down-regulation of the c-Met Inhibitor Cblb (Casitas B-lineage Lymphoma b)
    Shruti S. Desai et al, 2015, Journal of Biological Chemistry CrossRef
13. Epigenetic suppression of PGC1α (PPARGC1A) causes collateral sensitivity to HMGCR-inhibitors within BRAF-treatment resistant melanomas
    Jiaxin Liang et al, 2023, Nature Communications CrossRef
14. ROCK1 is a potential combinatorial drug target for BRAF mutant melanoma
    Marjon A Smit et al, 2014, Molecular Systems Biology CrossRef
15. Role of simvastatin in tumor lymphangiogenesis and lymph node metastasis
    Rui-Cheng Ji et al, 2018, Clinical & Experimental Metastasis CrossRef
16. Statins in oncological research: From experimental studies to clinical practice
    Peter Kubatka et al, 2014, Critical Reviews in Oncology/Hematology CrossRef
17. Simvastatin exhibits antiproliferative effects on spheres derived from canine mammary carcinoma cells
    CRISTIAN G TORRES et al, 2015, Oncology Reports CrossRef
18. Cholesterol and beyond - The role of the mevalonate pathway in cancer biology
    Andy Göbel et al, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
19. Atorvastatin decreases steroid production in H295R cells and in major endocrine tissues of male rats
    Cecilie Hurup Munkboel et al, 2018, Archives of Toxicology CrossRef
20. Acquired low cholesterol: diagnosis and relevance to safety of low LDL therapeutic targets
    Handrean Soran et al, 2018, Current Opinion in Lipidology CrossRef
21. Simvastatin decreases steroid production in the H295R cell line and decreases steroids and FSH in female rats
    Anna Guldvang et al, 2015, Reproductive Toxicology CrossRef